Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 912

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 912
---
 ​ | ​ | ​ | ​    | ​ |   209 | ​ | ​ |
| Total accrued expenses                     | ​ | ​ | ​                  | $ | 1,577 | ​ | ​ | ​ | ​    | $ | 1,786 | ​ | ​ |

7. Leases The Company has one operating lease pertaining to 5,969 square feet of corporate office space in Sugar Land, Texas pursuant to a lease agreement that commenced April 1, 2022. As of December 31, 2023 the remaining term of lease was 3.67 years. The lease requires monthly lease payments that are subject to annual increases throughout the lease term.

F-105

TABLE OF CONTENTS

7. Leases (continued) The components of lease costs, which are included within general and administrative expenses in the Company’s statements of operations and comprehensive loss were as follows (in thousands):

| ​                    
 ​                    | ​ 
 ​ | ​ 
 ​ | For the Year EndedDecember 31, 
 2023                           |   |     |   | ​ | ​ | 2022 |   |    |   | ​ 
 ​ |
|:---------------------|:--|:--|:-------------------------------|:--|----:|:--|:--|:--|:-----|:--|---:|:--|:--|
| Lease costs:         | ​ | ​ | ​                              | ​ |   ​ | ​ | ​ | ​ | ​    | ​ |  ​ | ​ | ​ |
| Operating lease cost | ​ | ​ | ​                              | $ |  90 | ​ | ​ | ​ | ​    | $ | 67 | ​ | ​ |
| Variable lease cost  | ​ | ​ | ​                              | ​ |  83 | ​ | ​ | ​ | ​    | ​ | 25 | ​ | ​ |
| Total lease costs    | ​ | ​ | ​                              | $ | 173 | ​ | ​ | ​ | ​    | ​ | 92 | ​ | ​ |

Supplemental disclosure of cash flow information related to the lease were as follows (in thousands):

| ​                                                                                            
 ​                                                                                            | ​ 
 ​ | ​ 
 ​ | For the Year EndedDecember 31, 
 2023                           |   |     |   | ​ | ​ | 2022 |   |     |   | ​ 
 ​ |
|:---------------------------------------------------------------------------------------------|:--|:--|: